Bio Protocol has officially launched its PEPTAI token on the Base chain, marking a significant step in decentralized science (DeSci) with the activation of an AI agent for peptide drug discovery. The token is available for claim via the Bio App, with 20% of the total supply allocated to BIO token stakers (veBIO holders). This allocation is vested over six months, with 20% available at the token generation event (TGE), while early full claiming incurs penalties on the unvested portion. Following its listing, PEPTAI's market capitalization briefly exceeded $15 million within five minutes, stabilizing at $13.5 million with a trading volume of $2.2 million. Investors are advised to exercise caution due to the high volatility of token prices.